Institutional investors hold a majority ownership of AGN through the 90.39% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended March 2016, these large investors purchased a net $2.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIRST MANHATTAN CO. Bought 374.4 Thousand shares of Allergan
SWEDBANK ROBUR FONDER AB Bought 282.9 Thousand shares of Allergan